tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
Advertisement

VistaGen Therapeutics (VTGN) Revenue

Compare
854 Followers

VistaGen Therapeutics Revenue

VistaGen Therapeutics had a revenue of 244.00K in the quarter ending Mar 31, 2026, with 1726.67%. This bring the company's revenue in the last twelve months to 646.00K, Decreased 32.92%. In the fiscal year ending Dec 31, 2025, VistaGen Therapeutics had annual revenue of 486.00K with -54.32% growth.
Revenue (ttm)
646.00K
Revenue Growth
-33.00%
P/S Ratio
195.70
Revenue/Employee
$10,125
Employees
48
Market Cap
$95.11M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
486.00K-578.00K-54.32%
Dec 31, 2024
1.06M1.29M-568.72%
Dec 31, 2023
-227.00K-1.34M-120.47%
Dec 31, 2022
1.11M19.40K+1.78%
Dec 31, 2021
1.09M+∞%
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00-1.25M-100.00%
Dec 31, 2017
1.25M+∞%
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis